NCT02390674View on ClinicalTrials.gov

Ciclosporin to Reduce Reperfusion Injury in Primary PCI

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

November 11, 2017

Conditions
Myocardial Reperfusion Injury
Interventions
DRUG

Ciclosporin

Comparison between ciclosporin and placebo

DRUG

Saline

Trial Locations (1)

NE2 4AE

Newcastle Clinical Trials Unit, Newcastle upon Tyne

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

Newcastle University

OTHER

lead

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

NCT02390674 - Ciclosporin to Reduce Reperfusion Injury in Primary PCI | Biotech Hunter | Biotech Hunter